Interestingly, the results showed that CRC patients with impaired receptor tyrosine kinase (RTK) pathway signaling displayed lower ACAA2 expression than those without impaired RTK (Figure 6A). The gene discussed is NTRK1; the disease is colorectal carcinoma.